IE45124B1 - Cyclopentanol lactones - Google Patents

Cyclopentanol lactones

Info

Publication number
IE45124B1
IE45124B1 IE601/77A IE60177A IE45124B1 IE 45124 B1 IE45124 B1 IE 45124B1 IE 601/77 A IE601/77 A IE 601/77A IE 60177 A IE60177 A IE 60177A IE 45124 B1 IE45124 B1 IE 45124B1
Authority
IE
Ireland
Prior art keywords
formula
radical
compounds
compound
acid
Prior art date
Application number
IE601/77A
Other languages
English (en)
Other versions
IE45124L (en
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of IE45124L publication Critical patent/IE45124L/xx
Publication of IE45124B1 publication Critical patent/IE45124B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IE601/77A 1976-03-19 1977-03-21 Cyclopentanol lactones IE45124B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7608004A FR2344285A1 (fr) 1976-03-19 1976-03-19 Nouvelles lactones derivees du cyclopentanol, leur procede de preparation et leur application comme medicaments

Publications (2)

Publication Number Publication Date
IE45124L IE45124L (en) 1977-09-19
IE45124B1 true IE45124B1 (en) 1982-06-30

Family

ID=9170682

Family Applications (1)

Application Number Title Priority Date Filing Date
IE601/77A IE45124B1 (en) 1976-03-19 1977-03-21 Cyclopentanol lactones

Country Status (20)

Country Link
JP (1) JPS52113956A (enrdf_load_stackoverflow)
AT (1) AT357275B (enrdf_load_stackoverflow)
AU (1) AU506760B2 (enrdf_load_stackoverflow)
BE (1) BE852624A (enrdf_load_stackoverflow)
CA (1) CA1094569A (enrdf_load_stackoverflow)
CH (1) CH620688A5 (enrdf_load_stackoverflow)
DE (1) DE2711950A1 (enrdf_load_stackoverflow)
DK (1) DK119377A (enrdf_load_stackoverflow)
ES (1) ES456999A1 (enrdf_load_stackoverflow)
FR (1) FR2344285A1 (enrdf_load_stackoverflow)
GB (1) GB1538717A (enrdf_load_stackoverflow)
HU (1) HU178332B (enrdf_load_stackoverflow)
IE (1) IE45124B1 (enrdf_load_stackoverflow)
IL (1) IL51690A (enrdf_load_stackoverflow)
LU (1) LU76976A1 (enrdf_load_stackoverflow)
NL (1) NL7703056A (enrdf_load_stackoverflow)
PT (1) PT66326B (enrdf_load_stackoverflow)
SE (1) SE436877B (enrdf_load_stackoverflow)
SU (2) SU749364A3 (enrdf_load_stackoverflow)
ZA (1) ZA771654B (enrdf_load_stackoverflow)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2439779A2 (fr) * 1976-03-19 1980-05-23 Roussel Uclaf Nouvelles lactones derivees du cyclopentanol, leur procede de preparation et leur application comme medicaments
FR2443466A1 (fr) * 1978-12-05 1980-07-04 Roussel Uclaf Nouvelles b-lactones derivees de l'acide 2-hydroxy cyclopentane carboxylique, leur procede de preparation et leur application comme medicaments
DE3722133A1 (de) * 1987-07-04 1989-01-12 Bayer Ag Azolyl-tetrahydropyran-derivate
EP1142886A1 (en) * 2000-04-07 2001-10-10 Aventis Pharma Deutschland GmbH Percyquinnin, a process for its production and its use as a pharmaceutical
BR0211204A (pt) * 2001-07-17 2004-07-13 Upjohn Co Processo e intermediários para preparar latanoprost
CN100417650C (zh) * 2006-08-17 2008-09-10 中国科学院昆明植物研究所 韧革菌素及其制备方法和在药物上的应用

Also Published As

Publication number Publication date
GB1538717A (en) 1979-01-24
FR2344285A1 (fr) 1977-10-14
LU76976A1 (enrdf_load_stackoverflow) 1977-10-03
NL7703056A (nl) 1977-09-21
SE436877B (sv) 1985-01-28
ATA195077A (de) 1979-11-15
ES456999A1 (es) 1978-01-16
AU2346677A (en) 1978-09-28
SU749364A3 (ru) 1980-07-15
JPS52113956A (en) 1977-09-24
AT357275B (de) 1980-06-25
SU745366A3 (ru) 1980-06-30
CH620688A5 (en) 1980-12-15
DK119377A (da) 1977-09-20
PT66326B (pt) 1979-01-18
IL51690A0 (en) 1977-05-31
PT66326A (fr) 1977-04-01
FR2344285B1 (enrdf_load_stackoverflow) 1979-02-02
SE7702908L (sv) 1977-09-20
IL51690A (en) 1982-02-28
JPS62146B2 (enrdf_load_stackoverflow) 1987-01-06
CA1094569A (fr) 1981-01-27
AU506760B2 (en) 1980-01-24
IE45124L (en) 1977-09-19
DE2711950A1 (de) 1977-09-29
HU178332B (en) 1982-04-28
BE852624A (fr) 1977-09-19
ZA771654B (en) 1978-04-26

Similar Documents

Publication Publication Date Title
Ireland et al. The total synthesis of ionophore antibiotics. A convergent synthesis of lasalocid A (X537A)
Takao et al. Novel total synthesis of (+)-eremantholide A
Posner et al. Diels-Alder cycloadditions using nucleophilic 3-(p-tolylthio)-2-pyrone. Regiocontrolled and stereocontrolled synthesis of unsaturated, bridged, bicyclic lactones
FR2466445A1 (fr) Formyl-2 bicyclo-alcanes, intermediaires de synthese d'isosteres de type 9-desoxy-9a-methylene de pgi2
Johnson et al. Prostaglandins. 2. Synthesis of prostaglandin F2. alpha. in optically active form from chiral precursors
US3773795A (en) 11-deoxy prostaglandin intermediates
Charlton et al. Asymmetric synthesis of (-)-neopodophyllotoxin
De Clercq et al. Total synthesis of (.+-.)-damsin
Hudlicky et al. Intramolecular cyclopentene annulation. 3. Synthesis and carbon-13 nuclear magnetic resonance spectroscopy of bicyclic cyclopentene lactones as potential perhydroazulene and/or monoterpene synthons
Marshall et al. Stereoselective synthesis of cycloalkene-fused butyrolactones via cyclopropylcarbinol solvolysis
IE45124B1 (en) Cyclopentanol lactones
US3532721A (en) Cyclopentyl-alkanoic acids
Bannai et al. Syntheses of isocarbacyclin by highly regioselective alkylation of allylic alcohols
Bindra et al. An efficient route to intermediates for the synthesis of 11-deoxyprostaglandins
Roush et al. Improved synthesis of the perhydroindenone precursor of dendrobine
US3883659A (en) 9-Oxaprostaglandin compositions
US5208258A (en) Antihypercholesterolemic compounds and synthesis thereof
EP1138679B1 (en) HYDRONAPHTHO 2,3-c]FURAN DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF
Li et al. Preparation of potential anti-inflammatory agents from dehydroabietic acid
IWATA et al. Synthetic Studies on Spiroketal Natural Products. III. Enantioselective Synthesis of 1, 6-Dioxaspiro [4.5] decane Compounds
US4011211A (en) Steroid total synthesis process utilizing asymmetric induction
US3644502A (en) Prostaglandin synthesis
US5191125A (en) Procedure for the preparation of bicyclo [3.2.0]hept-2-en-7-ones
US4054741A (en) Derivatives of prostanoic acid
CA1173051A (en) Total synthesis of 1rs,4r,5rs-4-(4,8- dimethyl-5-hydroxy-7-nonen-1-yl)-4-methyl-3, 8-dioxabicyclo¬3.2.1| octane-1-acetic acid